The role of interferon γ in regulation of CD4+ T-cells and its clinical implications

被引：54

作者：

Chen, Jiezhong ^{[1
]}

Liu, Xiaosong ^{[2
]}

机构：

[1] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia

[2] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia

来源：

CELLULAR IMMUNOLOGY | 2009年 / 254卷 / 02期

关键词：

Interferon gamma; Interferon gamma receptor; T-regulatory cells; CD4(+) T-cells; Apoptosis; Autoimmune diseases; Rheumatoid arthritis; Type; 1; diabetes; Multiple sclerosis; COLLAGEN-INDUCED ARTHRITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NILE-VIRUS-INFECTION; RECEPTOR-BETA CHAIN; IFN-GAMMA; MYCOBACTERIAL INFECTION; ORAL TOLERANCE; NOD MICE;

D O I：

10.1016/j.cellimm.2008.09.001

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Interferon gamma (IFN gamma) plays a central role in the immune response against infection and tumur immune surveillance. Its functions include not only activation of the host immune system to control microbial infections but also repression of autoimmune responses by turning on T-regulatory cells and increasing T effector cell apoptosis. Defects in IFN gamma and IFN gamma receptor genes have been associated with autoimmune diseases such as rheumatoid arthritis, type 1 diabetes and multiple sclerosis. However, treatment of autoimmune diseases by supplementing with IFN gamma has been satisfactory due to its broad biological effects. Instead, its target T-regulatory cells may be used for the clinical treatment of autoimmune diseases. Future study could also focus on promotion of the beneficial effects of IFN gamma and blocking those unwanted IFN gamma-induced activities. (c) 2008 Elsevier Inc. All rights reserved.

引用

页码：85 / 90

页数：6

共 50 条

[31] Importance of CD4+ helper T-cells in antitumor immunity
Shiku, H
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (05) : 435 - 438
[32] PKCtheta is required for Notch activation in CD4+ T-cells
Britton, G. J.
McNally, K.
Butterweck, P.
Burton, B. R.
Sabatos-Peyton, C. A.
Wuelfing, C.
Wraith, D. C.
IMMUNOLOGY, 2014, 143 : 74 - 74
[33] Importance of CD4+ Helper T-cells in Antitumor Immunity
Hiroshi Shiku
International Journal of Hematology, 2003, 77 : 435 - 438
[34] HELPER (CD4+) T-CELLS AND EOSINOPHILS IN ALLERGY AND ASTHMA
KAY, AB
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (02): : S22 - S26
[35] REGULATION OF CYTOKINE PRODUCTION AND RESPONSIVENESS OF HUMAN-MEMORY AND NAIVE CD4+ T-CELLS
ADIX, LM
LIPSKY, PE
DAVIS, LS
FASEB JOURNAL, 1991, 5 (06): : A1686 - A1686
[36] DYNAMICS OF HIV-INFECTION OF CD4+ T-CELLS
PERELSON, AS
KIRSCHNER, DE
DEBOER, R
MATHEMATICAL BIOSCIENCES, 1993, 114 (01) : 81 - 125
[37] PHENOTYPIC AND FUNCTIONAL-HETEROGENEITY OF CD4+ T-CELLS
POWRIE, F
MASON, D
IMMUNOLOGY TODAY, 1988, 9 (09): : 274 - 277
[38] Engineering liposomes as detection reagents for CD4+ T-cells
Edwards, Katie A.
Meyers, Katherine J.
Leonard, Barbara
Connelly, John T.
Wang, Yang
Holter, Tara
Baeumner, Antje J.
ANALYTICAL METHODS, 2012, 4 (12) : 3948 - 3955
[39] CD4+ T cells in atherosclerosis: Regulation by platelets
Li, Nailin
THROMBOSIS AND HAEMOSTASIS, 2013, 109 (06) : 980 - 990
[40] The regulation of CD4+ T cells during malaria
Kumar, Rajiv
Loughlan, Jessica R.
Ng, Susanna S.
Boyle, Michelle J.
Engwerda, Christian R.
IMMUNOLOGICAL REVIEWS, 2020, 293 (01) : 70 - 87

← 1 2 3 4 5 →